Items without sitelinks
Jump to navigation
Jump to search
Showing below up to 50 results in range #5,051 to #5,100.
- ornithine N-benzoyltransferase activity (Q17332)
- hallucinosis (Q17331)
- alcoholic hallucinosis (Q17330)
- citrullinase activity (Q17329)
- psychopathology (Q17328)
- affect lability (Q17327)
- 2,5-diaminovalerate transaminase activity (Q17326)
- delusional disorder (Q17325)
- delusion (Q17324)
- N5-(carboxyethyl)ornithine synthase activity (Q17323)
- list of language disorders (Q17322)
- language disorder (Q17321)
- paraphasia (Q17320)
- ornithine-acyl [acyl carrier protein] N-acyltransferase activity (Q17319)
- mental confusion (Q17318)
- disorientation (Q17317)
- scyllo-inosamine-4-phosphate amidinotransferase activity (Q17316)
- memory disorder (Q17315)
- amidinotransferase activity (Q17314)
- glycine amidinotransferase activity (Q17313)
- daydream (Q17312)
- acetylornithine deacetylase activity (Q17311)
- attentional control (Q17310)
- distraction (Q17309)
- delirium (Q17308)
- ornithine cyclodeaminase activity (Q17307)
- alcoholism therapy (Q17306)
- Alcohol detoxification (Q17305)
- ornithine decarboxylase activity (Q17304)
- substance-induced psychosis (Q17303)
- alcohol-induced mental disorder (Q17302)
- alcohol withdrawal syndrome (Q17301)
- delirium tremens (Q17300)
- ornithine carbamoyltransferase activity (Q17299)
- alcohol-related disorders (Q17298)
- glutamate N-acetyltransferase activity (Q17297)
- alcohol and health (Q17296)
- long-term effects of alcohol consumption (Q17295)
- flour treatment agent (Q17294)
- desire (Q17293)
- wish (Q17292)
- somnolence (Q17291)
- aminopropylagmatine ureohydrolase activity (Q17290)
- issue management (Q17289)
- ureidoglycolate lyase activity (Q17288)
- management process (Q17287)
- problem management (Q17286)
- disease management (Q17285)
- pain management (Q17284)
- methylguanidinase activity (Q17283)